VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WINT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WINTWindtree Therapeutics, Inc.
$0.01$387
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWINTQuarterly Financials

Windtree Therapeutics, Inc. (WINT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Windtree Therapeutics, Inc. (WINT) quarterly income statement — complete revenue, gross profit & net income history

WINT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue00090K00000000000000023.68M
Revenue Growth %----------------100%----
Cost of Goods Sold017K17K0127K24K21K22K14K120K0135K131K155K640K224K216K214K215K11.84M
COGS % of Revenue-------------------50%
Gross Profit0-17K-17K45K-127K-24K-21K-22K-14K-120K0-135K-131K-155K-640K-224K-216K-214K-215K11.84M
Gross Margin %---50%---------------50%
Gross Profit Growth %100%29.17%19.05%304.55%-807.14%80%-83.7%89.31%22.58%100%39.73%39.35%27.57%-197.67%-101.89%94.44%95.24%93.79%653.18%
Operating Expenses19.88M3.98M4.09M5.54M4.74M11.45M4.41M4.94M4.69M4.18M4.19M3.46M4.2M5.9M8.33M7.44M8.15M7.59M9.08M6.96M
OpEx % of Revenue---6156.67%---------------29.4%
Selling, General & Admin1.85M1.8M1.82M2.23M2.77M1.59M2.15M1.91M2.58M2.42M2.29M2.24M2.65M2.91M2.99M2.97M3.47M3.37M4.67M3.43M
SG&A % of Revenue---2476.67%---------------14.47%
Research & Development1.9M2.18M2.27M2.19M1.97M9.86M2.23M3.03M2.11M1.76M1.42M1.22M1.54M3M5.34M4.48M4.68M4.22M4.41M3.54M
R&D % of Revenue---2435.56%---------------14.93%
Other Operating Expenses1000K001000K0021K00-39K484K-286K569K201K218K-24K-53K-352K109K-496K
Operating Income-19.88M-3.98M-4.09M-5.54M-4.74M-11.45M-4.41M-4.96M-4.69M-6.76M-4.19M-10.81M-4.65M-17.54M-8.33M-14.69M-8.15M-45.36M-9.08M-6.96M
Operating Margin %----6156.67%----------------29.4%
Operating Income Growth %-319.36%65.21%7.15%-11.74%-1.09%-69.48%-5.11%54.13%-0.86%61.47%49.71%26.41%42.92%61.34%8.22%-111.06%6.41%-470.73%-35.45%-52.85%
EBITDA-19.52M-3.97M-4.07M-5.52M-4.61M-11.22M-4.38M-4.94M-4.68M-6.64M-4.17M-10.68M-4.52M-17.38M-7.69M-14.47M-7.93M-45.15M-8.86M-6.92M
EBITDA Margin %----6136.67%----------------29.22%
EBITDA Growth %-323.1%64.65%7.09%-11.87%1.33%-69.1%-5.18%53.76%-3.47%61.82%45.82%26.2%43.02%61.5%13.21%-109.11%8.46%-470.92%-33.07%-31.09%
D&A (Non-Cash Add-back)360K17K17K18K127K229K21K22K14K120K23K135K131K155K640K224K216K214K215K42K
EBIT-31.19M-10.55M-4.03M2.75M-2.94M-11.72M10.35M-5.14M-4.41M-6.59M-4.1M-11.05M-4.04M-17.32M-8.11M-14.71M-8.2M-45.67M-8.92M-7.45M
Net Interest Income430K119K-13K-53K-39K-90K17K49K99K95K32K39K25K4K-12K-12K-13K-7K9K3K
Interest Income758K198K7K8K12K20K30K61K112K108K44K52K39K17K1K1K1K39K50K7K
Interest Expense328K79K20K61K51K110K13K12K13K13K12K13K14K13K13K13K14K46K41K4K
Other Income/Expense-11.63M-6.65M45K8.23M1.75M-375K14.74M-195K265K156K80K-8M140K205K206K-7.29M-66K-359K118K-493K
Pretax Income-31.52M-10.63M-4.04M2.69M-2.99M-11.83M10.33M-5.15M-4.42M-6.6M-4.11M-11.06M-4.06M-17.33M-8.13M-14.73M-8.21M-45.72M-8.96M-7.45M
Pretax Margin %---2988.89%----------------31.48%
Income Tax-3.43M00-77K-240K197K114K0000-1.37M000-1.66M0-8.33M00
Effective Tax Rate %10.89%0%0%-2.86%8.03%-1.67%1.1%0%0%0%0%12.36%0%0%0%11.24%0%18.22%0%0%
Net Income-28.09M-10.64M-4.04M2.77M-2.75M-12.02M10.22M-5.15M-4.42M-6.6M-4.11M-9.69M-3.46M-17.13M-7.92M-13.07M-8.21M-37.39M-8.96M-7.45M
Net Margin %---3074.44%----------------31.48%
Net Income Growth %-921.64%11.51%-139.58%153.69%37.88%-82.15%348.58%46.82%-27.82%61.46%48.1%25.86%57.85%54.19%11.61%-75.38%8.95%-291.18%-37.14%-1.07%
Net Income (Continuing)-28.09M-10.63M-4.04M2.77M-2.75M-12.02M10.22M-5.15M-4.42M-6.6M-4.11M-9.69M-4.06M-17.33M-8.13M-13.07M-8.21M-37.39M-8.96M-7.45M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.08-3.06-4.630.27-211.39-1045.561098.83-773.54-773.60-1474.17-4287.26-11295.00-5862.15-26712.00-12924.00-20861.00-13840.00-63852.00-22788.00-19848.00
EPS Growth %99.49%99.71%-100.42%100.03%72.67%29.07%125.63%93.15%86.8%94.48%66.83%45.86%57.64%58.17%43.29%-5.1%43.47%-124.03%-6.16%31.03%
EPS (Basic)-1.08-3.06-4.630.27-211.39-1045.561098.83-773.54-773.60-1474.17-4287.26-11295.00-5862.15-26712.00-12924.00-20861.00-13840.00-63852.00-22788.00-19848.00
Diluted Shares Outstanding26.68K4.88K10.88K256.4K17.74K11.5K9.3K6.66K5.72K4.48K959858692649629627593586393376
Basic Shares Outstanding26.68K4.88K10.88K256.4K17.74K11.5K9.3K6.66K5.72K4.48K959858692649629627593586393376
Dividend Payout Ratio--------------------